HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

plagiochin E

reverses multidrug resistance; structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Benzylidene Compounds: 10
        Stilbenes: 657
        plagiochin E: 2
    - Bridged-Ring Compounds: 1
      - plagiochin E: 2
Polycyclic Compounds: 6
- Bridged-Ring Compounds: 1
  - plagiochin E: 2

Experts

1.	Hu, Zhi-min: 1 article (05/2010)
2.	Liu, Shang-ming: 1 article (05/2010)
3.	Lou, Hong-xiang: 1 article (05/2010)
4.	Qu, Jian-bo: 1 article (05/2010)
5.	Syed, Ali Kazim Abbas: 1 article (05/2010)
6.	Xu, Ai-hui: 1 article (05/2010)
7.	Yuan, Hui-qing: 1 article (05/2010)
8.	Cheng, Ai-Xia: 1 article (08/2009)
9.	Lou, Hong-Xiang: 1 article (08/2009)
10.	Sun, Ling-Mei: 1 article (08/2009)

Related Diseases

1.	Mitochondrial Diseases (Mitochondrial Disease) 08/01/2009 - "Plagiochin E, an antifungal bis(bibenzyl), exerts its antifungal activity through mitochondrial dysfunction-induced reactive oxygen species accumulation in Candida albicans."
2.	Prostatic Neoplasms (Prostate Cancer) 05/01/2010 - "To investigate the cytotoxic effects of four cyclic bisbibenzyls, Riccardin C (Ric), Pakyonol (Pak), Marchantin M (Mar), and Plagiochin E (Pla) against chemoresistant prostate cancer PC3 cells. "

Related Drugs and Biologics

1.	Reactive Oxygen Species (Oxygen Radicals)
2.	marchantin M
3.	pakyonol
4.	riccardin C